This product(s) resides on a APICMO contract.
The ability to produce, synthesize and manufacture large quantities of 6-bromo-3-hydroxypyrazine-2-carboxamide (259793-88-9) with quality control system under CGMP manufacturing
6-bromo-3-hydroxypyrazine-2-carboxamide (259793-88-9) Description
6-bromo-3-hydroxypyrazine-2-carboxamide is an intermediate typically in the synthesis of 6-bromo-3-hydroxypyrazine-2-carboxamide commercially named Favipiravir, which is a unique viral RNA Polymerase inhibitor for the treatment of Influenza (potentially treat the novel coronavirus pneumonia), acting on viral genetic copying to prevent its reproduction. A practical and step-economic route to Favipiravir. The complete synthesis of favipiravir from 2-aminopyrazine.
Favipiravir was approved for marketing in Japan in March 2014 and used for antiviral treatment of influenza A and B. In addition to the influenza virus, the drug also showed good antiviral activity to a variety of RNA viruses, such as Ebola virus, sand virus, Bunia virus, rabies virus, etc. Novel coronavirus pneumonia is inhibited by the latest research
This product(s) resides on a APICMO contract. If you are viewing this page as a non-registered user, the price(s) displayed is List Price. To view your pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. To place an order, contact APICMO Customer Service.
6-bromo-3-hydroxypyrazine-2-carboxamide (259793-88-9) Specifications
|Chemical Name or Material||6-Bromo-3-hydroxypyrazine-2-carboxamide; |
|Packaging||Aluminum Foil Bag|
|Molecular Weight (g/mol)||218.0|
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Bulk Ordering & Pricing:
Need larger quantities for your development, manufacturing or research applications?